ACCURAY INCORPORATED Capitalized Contract Cost, Net, Current
ACCURAY INCORPORATED (ARAY) had Capitalized Contract Cost, Net, Current of $1.69 million as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CapitalizedContractCostNetCurrent · last filed 2026-08-27
- 2026-06-30: Capitalized Contract Cost, Net, Current $1.69M.
- 2026-03-31: Capitalized Contract Cost, Net, Current $1.78M.
- 2025-12-31: Capitalized Contract Cost, Net, Current $1.84M.
- 2025-09-30: Capitalized Contract Cost, Net, Current $1.91M.
| Period end | Capitalized Contract Cost, Net, Current |
|---|---|
| 2026-06-30 | $1.69M 10-K · filed 2026-08-27 |
| 2026-03-31 | $1.78M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.84M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $1.91M 10-Q/A · filed 2026-02-17 |
| 2025-06-30 | $1.95M 10-K · filed 2026-08-27 |
| 2025-03-31 | $1.88M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $1.83M 10-Q · filed 2025-02-05 |
| 2024-09-30 | $1.89M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.88M 10-K/A · filed 2026-02-17 |
| 2024-03-31 | $1.83M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.80M 10-Q · filed 2024-02-07 |
| 2023-09-30 | $1.79M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.78M 10-K · filed 2024-09-19 |
| 2022-06-30 | $1.59M 10-K · filed 2023-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |